Resilience Training for Work-related Stress in Employees and the Influence of the Lecture Format on Training Success

NCT04897165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-06-08

No results posted yet for this study

Summary

A study to analyze the psychophysiological effects of a preventative, 4-week resilience training with mobile heart rate variability biofeedback (HRV-BfB) in a workplace setting and the influence of the lecture format (digital vs. live) on the training success.

Conditions

  • Work-Related Stress
  • Burnout

Interventions

OTHER

Resilience training with mobile HRV-BfB based on an e-learning approach (with digital lectures)

A 4-week resilience training with a mobile HRV-BfB device. Participants received access to three online lectures at the start of the first, third, and forth training week (each lasting 60 minutes) to receive a theoretical base on resilience and to learn how to exercise with the HRV-BfB device. Participants were asked to exercise three times a day for 5 minutes in their occupational and leisure time with the HRV-BfB device.

OTHER

Resilience training with mobile HRV-BfB based on a blended learning approach (with live lectures)

A 4-week resilience training with a mobile HRV-BfB device. Participants attended three live lectures at the start of the first, third, and forth training week (each lasting 90 minutes) to receive a theoretical base on resilience and to learn how to exercise with the HRV-BfB device. Participants were asked to exercise three times a day for 5 minutes in their occupational and leisure time with the HRV-BfB device.

Sponsors & Collaborators

  • ARCIM Institute Academic Research in Complementary and Integrative Medicine

    lead OTHER

Principal Investigators

  • Jan Vagedes · ARCIM Institute Academic Research in Complementary and Integrative Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-04
Primary Completion
2016-12-19
Completion
2016-12-19

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04897165 on ClinicalTrials.gov